These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 20636279)
1. An effective HIV vaccine: A combination of humoral and cellular immunity? Benmira S; Bhattacharya V; Schmid ML Curr HIV Res; 2010 Sep; 8(6):441-9. PubMed ID: 20636279 [TBL] [Abstract][Full Text] [Related]
2. Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans. Pissani F; Schulte B; Eller MA; Schultz BT; Ratto-Kim S; Marovich M; Thongcharoen P; Sriplienchan S; Rerks-Ngarm S; Pitisuttithum P; Esser S; Alter G; Robb ML; Kim JH; Michael NL; Streeck H J Virol; 2018 Dec; 92(23):. PubMed ID: 30209165 [TBL] [Abstract][Full Text] [Related]
10. Challenges in the development of an HIV-1 vaccine. Barouch DH Nature; 2008 Oct; 455(7213):613-9. PubMed ID: 18833271 [TBL] [Abstract][Full Text] [Related]
11. Prospects for a Globally Effective HIV-1 Vaccine. Excler JL; Robb ML; Kim JH Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S307-18. PubMed ID: 26590431 [TBL] [Abstract][Full Text] [Related]
12. Current views on the potential for development of a HIV vaccine. Cohen KW; Frahm N Expert Opin Biol Ther; 2017 Mar; 17(3):295-303. PubMed ID: 28095712 [TBL] [Abstract][Full Text] [Related]
13. HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen. Adis International Ltd Drugs R D; 2003; 4(4):249-53. PubMed ID: 12848591 [TBL] [Abstract][Full Text] [Related]
14. Heterologous HIV-based lentiviral/adenoviral vectors immunizations result in enhanced HIV-specific immunity. Asefa B; Korokhov N; Lemiale F Vaccine; 2010 Apr; 28(20):3617-24. PubMed ID: 20051277 [TBL] [Abstract][Full Text] [Related]
15. HIV vaccines in infants and children. Lambert JS Paediatr Drugs; 2005; 7(5):267-76. PubMed ID: 16220994 [TBL] [Abstract][Full Text] [Related]
16. Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design. Srivastava IK; Ulmer JB; Barnett SW Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S33-52. PubMed ID: 15285704 [TBL] [Abstract][Full Text] [Related]